{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "Causality.html": {"id": "Causality.html", "text": "Causality", "displayed_text": "Causality"}, "Causality Examples.html": {"id": "Causality Examples.html", "text": "Causality Examples", "displayed_text": "Causality Examples"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Medicine_465_r": {"DOI": "10.1038/s41467-018-04133-8", "id": "Medicine_465_r", "News Finding": "The results of this study provide new insight into the channel function.", "Paper Finding": "It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement.", "News Context": "In the context of drug delivery, this platform is considered 'drug-agnostic,' which simply means the same membrane technology can be used for a wide spectrum of drugs, and just the size of the channel is what needs to be customized. The results of this study provide new insight into the channel function. Upon putting them to the test, however, they discovered intriguing, unexpected molecular behavior in these channels.", "Paper Context": "3 and Supplementary Fig. It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement. Figure 2b exhibits release curves of anionic cefazolin, (3-aminosalicylic acid in Supplementary Fig.", "scores": "[4.0, 3.0, 5.0, 1.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://healthmedicinet.com/news/discovery-will-impact-design-of-drug-delivery-systems-at-the-molecular-level/", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: In the context of drug delivery, this platform is considered \\'drug-agnostic,\\' which simply means the same membrane technology can be used for a wide spectrum of drugs, and just the size of the channel is what needs to be customized. The results of this study provide new insight into the channel function. Upon putting them to the test, however, they discovered intriguing, unexpected molecular behavior in these channels.\"><b>Finding:</b></span> The results of this study provide new insight into the channel function.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: In the context of drug delivery, this platform is considered 'drug-agnostic,' which simply means the same membrane technology can be used for a wide spectrum of drugs, and just the size of the channel is what needs to be customized. The results of this study provide new insight into the channel function. Upon putting them to the test, however, they discovered intriguing, unexpected molecular behavior in these channels.\"><b>Finding:</b></span> The results of this study provide new insight into the channel function."}, "Medicine_465_p": {"DOI": "10.1038/s41467-018-04133-8", "id": "Medicine_465_p", "News Finding": "The results of this study provide new insight into the channel function.", "Paper Finding": "It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement.", "News Context": "In the context of drug delivery, this platform is considered 'drug-agnostic,' which simply means the same membrane technology can be used for a wide spectrum of drugs, and just the size of the channel is what needs to be customized. The results of this study provide new insight into the channel function. Upon putting them to the test, however, they discovered intriguing, unexpected molecular behavior in these channels.", "Paper Context": "3 and Supplementary Fig. It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement. Figure 2b exhibits release curves of anionic cefazolin, (3-aminosalicylic acid in Supplementary Fig.", "scores": "[4.0, 3.0, 5.0, 1.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://healthmedicinet.com/news/discovery-will-impact-design-of-drug-delivery-systems-at-the-molecular-level/", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: 3 and Supplementary Fig. It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement. Figure 2b exhibits release curves of anionic cefazolin, (3-aminosalicylic acid in Supplementary Fig.\"><b>Finding:</b></span> It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement.']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: 3 and Supplementary Fig. It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement. Figure 2b exhibits release curves of anionic cefazolin, (3-aminosalicylic acid in Supplementary Fig.\"><b>Finding:</b></span> It is important to note that obtaining a linear release profile for a molecule carrying a charge of sign opposite to that of the channel surfaces is trivial: as a matter of fact, it is a previously unreported achievement."}, "Medicine_238_r": {"DOI": "10.1001/jamapsychiatry.2015.0500", "id": "Medicine_238_r", "News Finding": "Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study.", "Paper Finding": "Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) .", "News Context": "\"We may need to put greater effort into increasing access to psychosocial interventions that can treat symptoms and behaviors that are currently being addressed with antipsychotic medications.\" Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study. Olfson pointed out that more research is needed to determine the factors that are currently impeding access to psychotherapy for children and teens in need of it.", "Paper Context": "Among antipsychotic-treated children and adolescents with mental disorder claims, the most common diagnosis was ADHD (younger children, 52.5%; older children, 60.1%; adolescents, 34.9%), while depression was the most common diagnosis among young adults (34.5%), followed by bipolar (26.6%) and anxiety disorders (22.9%). Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) . In contrast with earlier reports 7-9 of increasing antipsychotic treatment of US children through the early 2000s, the percentage of children treated with antipsychotics was lower in 2010 than in 2006.", "scores": "[5.0, 2.0, 3.0, 2.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://www.medicaldaily.com/prescription-drug-use-retrospective-study-shows-decreased-antipsychotic-drug-340770", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"We may need to put greater effort into increasing access to psychosocial interventions that can treat symptoms and behaviors that are currently being addressed with antipsychotic medications.\" Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study. Olfson pointed out that more research is needed to determine the factors that are currently impeding access to psychotherapy for children and teens in need of it.\"><b>Finding:</b></span> Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"We may need to put greater effort into increasing access to psychosocial interventions that can treat symptoms and behaviors that are currently being addressed with antipsychotic medications.\" Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study. Olfson pointed out that more research is needed to determine the factors that are currently impeding access to psychotherapy for children and teens in need of it.\"><b>Finding:</b></span> Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study."}, "Medicine_238_p": {"DOI": "10.1001/jamapsychiatry.2015.0500", "id": "Medicine_238_p", "News Finding": "Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study.", "Paper Finding": "Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) .", "News Context": "\"We may need to put greater effort into increasing access to psychosocial interventions that can treat symptoms and behaviors that are currently being addressed with antipsychotic medications.\" Psychotherapy has made progress but is still being utilized by only a small portion of young people being treated with antipsychotics, according to the study. Olfson pointed out that more research is needed to determine the factors that are currently impeding access to psychotherapy for children and teens in need of it.", "Paper Context": "Among antipsychotic-treated children and adolescents with mental disorder claims, the most common diagnosis was ADHD (younger children, 52.5%; older children, 60.1%; adolescents, 34.9%), while depression was the most common diagnosis among young adults (34.5%), followed by bipolar (26.6%) and anxiety disorders (22.9%). Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) . In contrast with earlier reports 7-9 of increasing antipsychotic treatment of US children through the early 2000s, the percentage of children treated with antipsychotics was lower in 2010 than in 2006.", "scores": "[5.0, 2.0, 3.0, 2.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://www.medicaldaily.com/prescription-drug-use-retrospective-study-shows-decreased-antipsychotic-drug-340770", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Among antipsychotic-treated children and adolescents with mental disorder claims, the most common diagnosis was ADHD (younger children, 52.5%; older children, 60.1%; adolescents, 34.9%), while depression was the most common diagnosis among young adults (34.5%), followed by bipolar (26.6%) and anxiety disorders (22.9%). Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) . In contrast with earlier reports 7-9 of increasing antipsychotic treatment of US children through the early 2000s, the percentage of children treated with antipsychotics was lower in 2010 than in 2006.\"><b>Finding:</b></span> Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) .']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Among antipsychotic-treated children and adolescents with mental disorder claims, the most common diagnosis was ADHD (younger children, 52.5%; older children, 60.1%; adolescents, 34.9%), while depression was the most common diagnosis among young adults (34.5%), followed by bipolar (26.6%) and anxiety disorders (22.9%). Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) . In contrast with earlier reports 7-9 of increasing antipsychotic treatment of US children through the early 2000s, the percentage of children treated with antipsychotics was lower in 2010 than in 2006.\"><b>Finding:</b></span> Less than one-fourth of the patients in each of the age groups had an outpatient claim for psychotherapy (younger children, 13.5%; older children, 20.4%; adolescents, 24.8%; young adults, 18.8%) ( Table 4) ."}, "test_question_testing_Explicitly states: no relation": {"id": "test_question_testing_Explicitly states: no relation", "text": "<b>Reported Finding:</b> Exposure to traffic noise at the office increases stress levels. This is a test question, please select Explicitly states: no relation. Do not mark any words or phrases.", "displayed_text": "<b>Reported Finding:</b> Exposure to traffic noise at the office increases stress levels. This is a test question, please select Explicitly states: no relation. Do not mark any words or phrases."}, "Medicine_49_r": {"DOI": "10.1038/s41589-018-0155-8", "id": "Medicine_49_r", "News Finding": "The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue.", "Paper Finding": "We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig.", "News Context": "\"This is a good example of how the study of a rare genetic disease can reveal a pathway that plays a key role in human biology,\" says study co-senior author Benjamin Cravatt, professor and chair of the Department of Chemical Physiology at Scripps Research. The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue. The rise wasn't as great as that seen in the ABHD12-knockout mice, and even four weeks of treatment with the inhibitor appeared to cause only slight hearing defects -- nothing like the profound defects experienced by PHARC patients.", "Paper Context": "), which adopt a more macrophage-like cell state compared to undifferentiated THP-1 cells. We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig. 16 ) and alters lyso-PS and PS content in primary human macrophages, which showed elevations in both lyso-PS and 20:4 PS following 4 or 24 h treatment with DO264 (1 \u00b5 M), but not (S)-DO271 (1 \u00b5 M) ( Fig.", "scores": "[4.0, 5.0, 1.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://ct.moreover.com/?a=37814264274&p=1pl&v=1&x=fV_-TrzPs9X1ZtNnkmq4RQ", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"This is a good example of how the study of a rare genetic disease can reveal a pathway that plays a key role in human biology,\" says study co-senior author Benjamin Cravatt, professor and chair of the Department of Chemical Physiology at Scripps Research. The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue. The rise wasn\\'t as great as that seen in the ABHD12-knockout mice, and even four weeks of treatment with the inhibitor appeared to cause only slight hearing defects -- nothing like the profound defects experienced by PHARC patients.\"><b>Finding:</b></span> The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"This is a good example of how the study of a rare genetic disease can reveal a pathway that plays a key role in human biology,\" says study co-senior author Benjamin Cravatt, professor and chair of the Department of Chemical Physiology at Scripps Research. The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue. The rise wasn't as great as that seen in the ABHD12-knockout mice, and even four weeks of treatment with the inhibitor appeared to cause only slight hearing defects -- nothing like the profound defects experienced by PHARC patients.\"><b>Finding:</b></span> The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue."}, "Medicine_49_p": {"DOI": "10.1038/s41589-018-0155-8", "id": "Medicine_49_p", "News Finding": "The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue.", "Paper Finding": "We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig.", "News Context": "\"This is a good example of how the study of a rare genetic disease can reveal a pathway that plays a key role in human biology,\" says study co-senior author Benjamin Cravatt, professor and chair of the Department of Chemical Physiology at Scripps Research. The team found that in adult mice, reducing ABHD12 activity with the inhibitor led to a rise in lyso-PS in immune cells called macrophages, as well as in brain tissue. The rise wasn't as great as that seen in the ABHD12-knockout mice, and even four weeks of treatment with the inhibitor appeared to cause only slight hearing defects -- nothing like the profound defects experienced by PHARC patients.", "Paper Context": "), which adopt a more macrophage-like cell state compared to undifferentiated THP-1 cells. We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig. 16 ) and alters lyso-PS and PS content in primary human macrophages, which showed elevations in both lyso-PS and 20:4 PS following 4 or 24 h treatment with DO264 (1 \u00b5 M), but not (S)-DO271 (1 \u00b5 M) ( Fig.", "scores": "[4.0, 5.0, 1.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://ct.moreover.com/?a=37814264274&p=1pl&v=1&x=fV_-TrzPs9X1ZtNnkmq4RQ", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: ), which adopt a more macrophage-like cell state compared to undifferentiated THP-1 cells. We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig. 16 ) and alters lyso-PS and PS content in primary human macrophages, which showed elevations in both lyso-PS and 20:4 PS following 4 or 24 h treatment with DO264 (1 \u00b5 M), but not (S)-DO271 (1 \u00b5 M) ( Fig.\"><b>Finding:</b></span> We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig.']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: ), which adopt a more macrophage-like cell state compared to undifferentiated THP-1 cells. We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig. 16 ) and alters lyso-PS and PS content in primary human macrophages, which showed elevations in both lyso-PS and 20:4 PS following 4 or 24 h treatment with DO264 (1 \u00b5 M), but not (S)-DO271 (1 \u00b5 M) ( Fig.\"><b>Finding:</b></span> We also found that DO264 inhibits ABHD12 activity ( Supplementary Fig."}, "test_question_testing_Causation": {"id": "test_question_testing_Causation", "text": "<b>Reported Finding:</b> Exposure to traffic noise at the office increases stress levels. This is a test question, please select Causation. Do not mark any words or phrases.", "displayed_text": "<b>Reported Finding:</b> Exposure to traffic noise at the office increases stress levels. This is a test question, please select Causation. Do not mark any words or phrases."}, "Medicine_107_r": {"DOI": "10.1111/1365-2656.12871", "id": "Medicine_107_r", "News Finding": "Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute.", "Paper Finding": "Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals.", "News Context": "\"The effect of RHDV disease virus on rabbits is enhanced by previous infection with MYXV virus. Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute. \"The findings suggest a continuous benefit from both viruses and maximum impact on rabbit numbers if they act together.\"", "Paper Context": "Individuals susceptible to both RHDV and MYXV had significantly higher survival rates than immune rabbits in all seasons (all odd ratio 1.13-1.67 with CIs between 1.02 and 1.99; Figure 2 and Supporting Information Figure   S3 ). Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals. Young rabbits, including those with maternal antibodies to either virus, had significantly lower survival rates than immune rabbits in spring (Figure 2 and Supporting Information Figure S4 ), indicating that waning protection by antibodies result in infection and potentially, mortality, later in the same year.", "scores": "[4.0, 3.0, 3.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.8, "source": "news", "News URL": "http://ct.moreover.com/?a=34506942217&p=1pl&v=1&x=OCP5j07SbNKK_Tx7JPH1Dw", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"The effect of RHDV disease virus on rabbits is enhanced by previous infection with MYXV virus. Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University\\'s Environment Institute. \"The findings suggest a continuous benefit from both viruses and maximum impact on rabbit numbers if they act together.\"\"><b>Finding:</b></span> Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University\\'s Environment Institute.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: \"The effect of RHDV disease virus on rabbits is enhanced by previous infection with MYXV virus. Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute. \"The findings suggest a continuous benefit from both viruses and maximum impact on rabbit numbers if they act together.\"\"><b>Finding:</b></span> Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute."}, "Medicine_107_p": {"DOI": "10.1111/1365-2656.12871", "id": "Medicine_107_p", "News Finding": "Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute.", "Paper Finding": "Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals.", "News Context": "\"The effect of RHDV disease virus on rabbits is enhanced by previous infection with MYXV virus. Survival rates were lowest for rabbits which survived MYXV infection and then were exposed to RHDV disease,\" says Dr Fordham from the University's Environment Institute. \"The findings suggest a continuous benefit from both viruses and maximum impact on rabbit numbers if they act together.\"", "Paper Context": "Individuals susceptible to both RHDV and MYXV had significantly higher survival rates than immune rabbits in all seasons (all odd ratio 1.13-1.67 with CIs between 1.02 and 1.99; Figure 2 and Supporting Information Figure   S3 ). Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals. Young rabbits, including those with maternal antibodies to either virus, had significantly lower survival rates than immune rabbits in spring (Figure 2 and Supporting Information Figure S4 ), indicating that waning protection by antibodies result in infection and potentially, mortality, later in the same year.", "scores": "[4.0, 3.0, 3.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.8, "source": "news", "News URL": "http://ct.moreover.com/?a=34506942217&p=1pl&v=1&x=OCP5j07SbNKK_Tx7JPH1Dw", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Individuals susceptible to both RHDV and MYXV had significantly higher survival rates than immune rabbits in all seasons (all odd ratio 1.13-1.67 with CIs between 1.02 and 1.99; Figure 2 and Supporting Information Figure   S3 ). Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals. Young rabbits, including those with maternal antibodies to either virus, had significantly lower survival rates than immune rabbits in spring (Figure 2 and Supporting Information Figure S4 ), indicating that waning protection by antibodies result in infection and potentially, mortality, later in the same year.\"><b>Finding:</b></span> Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals.']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Individuals susceptible to both RHDV and MYXV had significantly higher survival rates than immune rabbits in all seasons (all odd ratio 1.13-1.67 with CIs between 1.02 and 1.99; Figure 2 and Supporting Information Figure   S3 ). Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals. Young rabbits, including those with maternal antibodies to either virus, had significantly lower survival rates than immune rabbits in spring (Figure 2 and Supporting Information Figure S4 ), indicating that waning protection by antibodies result in infection and potentially, mortality, later in the same year.\"><b>Finding:</b></span> Crucially, we found relatively higher survival rates of individuals susceptible to both viruses compared to those susceptible to RHDV and immune to MYXV throughout the year (Figure 2 ), indicating that rabbits immune to MYXV have a lower survival rate than susceptible individuals."}, "Medicine_41_r": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_41_r", "News Finding": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.", "Paper Finding": "Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding.", "News Context": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.", "Paper Context": "The median age of trial participants was 62 years (range, 53-74), 77 501 (47%) were men, 30 361 (19%) had diabetes, and the median baseline risk of the primary cardiovascular outcome was 9.2% (range, 2.6%-15.9%). Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding. This information may inform discussions with patients about aspirin for primary prevention of cardiovascular events and bleeding.", "scores": "[5.0, 5.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 4.333333333333333, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2019/01/190122114950.htm", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\\n\\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.\"><b>Finding:</b></span> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.\"><b>Finding:</b></span> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding."}, "Medicine_41_p": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_41_p", "News Finding": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.", "Paper Finding": "Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding.", "News Context": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.", "Paper Context": "The median age of trial participants was 62 years (range, 53-74), 77 501 (47%) were men, 30 361 (19%) had diabetes, and the median baseline risk of the primary cardiovascular outcome was 9.2% (range, 2.6%-15.9%). Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding. This information may inform discussions with patients about aspirin for primary prevention of cardiovascular events and bleeding.", "scores": "[5.0, 5.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 4.333333333333333, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2019/01/190122114950.htm", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: The median age of trial participants was 62 years (range, 53-74), 77 501 (47%) were men, 30 361 (19%) had diabetes, and the median baseline risk of the primary cardiovascular outcome was 9.2% (range, 2.6%-15.9%). Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding. This information may inform discussions with patients about aspirin for primary prevention of cardiovascular events and bleeding.\"><b>Finding:</b></span> Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding.']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: The median age of trial participants was 62 years (range, 53-74), 77 501 (47%) were men, 30 361 (19%) had diabetes, and the median baseline risk of the primary cardiovascular outcome was 9.2% (range, 2.6%-15.9%). Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding. This information may inform discussions with patients about aspirin for primary prevention of cardiovascular events and bleeding.\"><b>Finding:</b></span> Aspirin use was associated with significant reductions in the composite cardiovascular outcome compared with no aspirin (57.1 per 10 000 participant-years with aspirin and 61.4 per 10 000 participant-years with no aspirin) (hazard ratio CONCLUSIONS AND RELEVANCE The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding."}, "Medicine_94_r": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_94_r", "News Finding": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.", "Paper Finding": "The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude.", "News Context": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.", "Paper Context": "6 This study showed that when analysis was restricted to populations with observation-derived 10-year cardiovascular event rate estimates of 10% or more, aspirin use was associated with an absolute risk decrease of 0.51% (5% CI, 0.06%-0.3%) for the cardiovascular composite outcome, but an absolute risk increase of 0.64% (5% CI, 0.35%-0.7%) for major bleeding. The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude. Aspirin use was not associated with a reduction in cardiovascular mortality, and deaths due to bleeding were rare.", "scores": "[5.0, 4.0, 1.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2019/01/190122114950.htm", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\\n\\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.\"><b>Finding:</b></span> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.\"><b>Finding:</b></span> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding."}, "Medicine_94_p": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_94_p", "News Finding": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.", "Paper Finding": "The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude.", "News Context": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.", "Paper Context": "6 This study showed that when analysis was restricted to populations with observation-derived 10-year cardiovascular event rate estimates of 10% or more, aspirin use was associated with an absolute risk decrease of 0.51% (5% CI, 0.06%-0.3%) for the cardiovascular composite outcome, but an absolute risk increase of 0.64% (5% CI, 0.35%-0.7%) for major bleeding. The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude. Aspirin use was not associated with a reduction in cardiovascular mortality, and deaths due to bleeding were rare.", "scores": "[5.0, 4.0, 1.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2019/01/190122114950.htm", "text": "['<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: 6 This study showed that when analysis was restricted to populations with observation-derived 10-year cardiovascular event rate estimates of 10% or more, aspirin use was associated with an absolute risk decrease of 0.51% (5% CI, 0.06%-0.3%) for the cardiovascular composite outcome, but an absolute risk increase of 0.64% (5% CI, 0.35%-0.7%) for major bleeding. The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude. Aspirin use was not associated with a reduction in cardiovascular mortality, and deaths due to bleeding were rare.\"><b>Finding:</b></span> The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude.']", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: 6 This study showed that when analysis was restricted to populations with observation-derived 10-year cardiovascular event rate estimates of 10% or more, aspirin use was associated with an absolute risk decrease of 0.51% (5% CI, 0.06%-0.3%) for the cardiovascular composite outcome, but an absolute risk increase of 0.64% (5% CI, 0.35%-0.7%) for major bleeding. The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude. Aspirin use was not associated with a reduction in cardiovascular mortality, and deaths due to bleeding were rare.\"><b>Finding:</b></span> The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}